问题 › 是否应该收购竞争对手？ › 律所
收购失败更多源于整合而非价格，而整合成本中因利用率下降和锁定期延长造成的损失，是最不可能被建模的数字。 这个问题在律所的版本并非通用版本。19 of 28名55岁以上股权合伙人，过去八年既无正式横向招聘计划，也无从律师到合伙人的培养通道，因此忽略82 %实现率的答案必然错误。分析必须从68 %利用率和£184 k每股权合伙人利润出发，而非从收入出发。
收购失败更多源于整合而非价格，而整合成本中因利用率下降和锁定期延长造成的损失，是最不可能被建模的数字。 这个问题在律所的版本并非通用版本。19 of 28名55岁以上股权合伙人，过去八年既无正式横向招聘计划，也无从律师到合伙人的培养通道，因此忽略82 %实现率的答案必然错误。分析必须从68 %利用率和£184 k每股权合伙人利润出发，而非从收入出发。
收购竞争对手的理由通常建立在合并五个业务组产生的收入协同上，而这是最不可靠且最慢到来的收益类别。支持职能的成本协同更可预测，但鉴于当前实现率和利用率，真实数字通常小于模型假设。
决定多数结果的数字是整合成本——收费律师对齐、股权合伙人角色、客户流失，以及一年或更长时间内管理层注意力从现有业务转移。这项成本因难以估算且未出现在任何一方账目中而被常规忽略。
严谨版本会问：具体而言，你获得的是什么、无法通过其他更低成本方式构建或买到；若所有收入协同均未实现，业务会变成什么样子。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 股权合伙人围绕五个业务组间的交叉销售构建理由，却未量化对利用率或实现率的影响。
✓ 合伙人会议中列出整合步骤，却未对锁定期天数或每股权合伙人利润作出调整。
✓ 收购讨论与横向招聘计划缺失、从律师到合伙人通道停滞并列。
通常会让情况更糟的做法。 以收入协同为交易定价依据，而这些协同通常晚到、规模小于模型或根本不会出现。
It is for you if you run or finance a law firm and the rationale leans on cross-selling to each other's customers. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家律所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Ashgrove Legal LLP, a sample company profile used for testing rather than a customer — £24.8 m gross revenue from five practice groups.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Scale the only practice hitting 88 % realisation to fund its own growth and close the succession gap.
| Investment required | £240 k (remaining FY2026 discretionary cap after £180 k IT commitment) |
| Expected return | 1.4–1.6× cash-on-cash within 24 months at current realisation rates. |
| Revenue, year 1 | £25.4–25.7 m firm-wide (+£0.6–0.9 m incremental) |
| Revenue, year 2 | £26.5–27.1 m firm-wide (+£1.1–1.3 m incremental from B&F segment) |
| Revenue, year 3 | £27.8–28.6 m firm-wide (+£1.3–1.5 m incremental) |
| Exit criteria | Strategy must be reversed if, within 18 months, segment revenue has not reached £2.4 m annualised OR cumulative net profit contribution is below £150 k, OR if any lateral hire’s personal billings fall below 1 200 hours in any rolling 6-month period. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For 律所 it works through 82 % realisation, 68 % utilisation, £184 k profit per equity partner and 112 lock-up days, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
估值两次——一次按独立价值，一次按其对你而言的具体价值。两者差额即你能支付并仍创造价值的上限，通常比预期更窄。
成本协同远更可靠。它们在你控制范围内且可排期。收入协同取决于客户是否按模型行事，这是最常出错的假设。
整合消耗的管理注意力超出任何预算，导致两家企业在交易本应回本的期间均表现不佳。
Materially, yes. 19 of 28 equity partners aged 55 or over with no formal lateral hire programme or associate-to-partner track for eight years — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82 % realisation, 68 % utilisation, £184 k profit per equity partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82 % realisation and 68 % utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית